Brian Henick, MD

Specialties:
Hematology/Oncology, Internal Medicine
More specialties
Accepting New Patients
Virtual Visits/Telehealth
Profile Headshot

Overview

Dr. Henick is a medical oncologist specializing in the care of patients with malignancies of the aerodigestive tract. As the Associate Director of Experimental Therapeutics and Director of Translational Research in Aerodigestive Cancers in Medical Oncology, Dr. Henick’s clinical care and research are aligned to improve the effectiveness of, and limit toxicity from, emerging cancer treatments. These efforts entail clinical trials that Dr. Henick has written and leads to study novel therapeutic approaches and to reduce steroid dependence among patients experiencing adverse events from immunotherapy. 


Areas of Expertise / Conditions Treated

  • Esophageal Cancer
  • Immunotherapy
  • Lung Cancer
  • Mesothelioma
  • Thoracic Cancer
  • Thoracic Lung Cases
  • Thoracic Oncology
  • Thymoma

Academic Appointments

  • Assistant Professor of Medicine at CUMC

Administrative Titles

  • Associate Director, Experimental Therapeutics
  • Director of Translational Research, Upper Aerodigestive Cancers in Medical Oncology

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center

Gender

  • Male

Schedule an Appointment

Virtual Visits/Telehealth

Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.

Schedule Virtual Visit

Phone Appointments

Existing Patients:
New Patients:

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Location(s)

161 Fort Washington Avenue
New York, NY 10032

Insurance Accepted

Aetna

  • Aetna Signature Administrators
  • EPO
  • HMO
  • Medicare Managed Care
  • NYP Employee Plan
  • NY Signature
  • POS
  • PPO
  • Student Health

Affinity Health Plan

  • Essential Plan
  • Medicaid Managed Care

AgeWell

  • Medicare Managed Care
  • Special Needs

Amida Care

  • Special Needs

Cigna

  • EPO
  • Great West (National)
  • HMO
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross/Blue Shield

  • EPO
  • HMO
  • Medicare Managed Care
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare (National)

  • MagnaCare

Medicare

  • Railroad
  • Traditional Medicare

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Oxford Health Plans

  • Freedom
  • Liberty

RiverSpring

  • Special Needs

UnitedHealthcare

  • Compass (Exchange)
  • Empire Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth
  • Special Needs

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • New Jersey Medical School
  • Internship: Yale New Haven Hospital
  • Residency: Yale New Haven Hospital
  • Fellowship: Yale New Haven Hospital

Board Certifications

  • Internal Medicine

Honors & Awards

Gold Humanism Honor Society (2011)

CCF/ASCO Young Investigator Award (2017)

SITC Sparkathon (2017-18)

CCF/ASCO Merit Award (2018)

ASCO Journals Editorial Fellowship (2018)

Research

Collaborating with several laboratories at the HICCC (especially Dr. Hiroshi Nakagawa, Dr. Steven Reiner and Dr. Anil K. Rustgi), Dr. Henick is developing personalized blood- and imaging-based biomarkers to guide precision cancer therapy, and to leverage cutting-edge model systems to test and enhance novel treatment approaches. Dr. Henick has presented his work at national conferences such as ASCO, and his accolades include induction to the Gold Humanism Honor Society, research awards from the EGFR Resisters and Conquer Cancer Foundation/ASCO, and selection to the SITC Sparkathon and IASLC Academy. He was a Top Reviewer for the Journal of Clinical Oncology, Precision Oncology, where he was the inaugural Editorial Fellow and currently serves on the editorial board.

A “Minority/Underserved-NCORP Champion”, Dr. Henick is committed to enhancing representation of underserved minority groups in our clinical trials to help assure that all patients may benefit from the results of his research. He will be Columbia’s site lead for an upcoming NYC-wide effort to study the effects of immunotherapy in underserved minority patients with lung cancer.